Age, Biography and Wiki
Pierre Corvol was born on 18 August, 1941 in Boulogne-Billancourt, France, is a French doctor and biology researcher (born 1941). Discover Pierre Corvol's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 82 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
82 years old |
| Zodiac Sign |
Leo |
| Born |
18 August, 1941 |
| Birthday |
18 August |
| Birthplace |
Boulogne-Billancourt, France |
| Nationality |
France
|
We recommend you to check the complete list of Famous People born on 18 August.
He is a member of famous doctor with the age 82 years old group.
Pierre Corvol Height, Weight & Measurements
At 82 years old, Pierre Corvol height not available right now. We will update Pierre Corvol's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Pierre Corvol Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Pierre Corvol worth at the age of 82 years old? Pierre Corvol’s income source is mostly from being a successful doctor. He is from France. We have estimated Pierre Corvol's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
doctor |
Pierre Corvol Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Pierre Corvol (born 18 August 1941) is a French doctor and biology researcher.
He served as resident at academic hospitals of Paris (1964), and spent post-doctoral research at the National Institutes of Health in Bethesda, Maryland, USA, in 1969.
He became an associate professor at CHU Broussais Hôtel-Dieu in 1976.
In 1983, he took over the management of Inserm's U36 (Vascular Pathology and Renal Endocrinology) and was elected as the chairman of the experimental medicine department at the Collège de France in 1989, a position he held until 2012.
He was a member of Inserm's Scientific Steering Committee from 1985 to 1992 and played a major role in the creation of Clinical Investigation Centres (1990-1992), which allowed clinical research in hospitals.
Corvol chaired the Scientific Council of the Foundation for Medical Research (1995-1998), the Scientific Council of Inserm (1999-2003), the Board of Directors of the École normale supérieure (2001-2004), and the Scientific Council of the Assistance public-Hôpitaux de Paris (2004-2006).
He became a full member of the French Academy of Sciences in 1995, and President in 2019.
He holds an honorary doctorate from the Universities of Lausanne (1997), Geneva (2006) and Semmelweis University of Budapest (2012).
He has also received the following
His publications include:
He was elected a member of the American Academy of Arts and Sciences in 2000.
He was director of the Collège de France from 2006 to August 2012.
Corvol studied at the Lycée Condorcet in Paris, France.
He was director of the Collège de France from 2006 to August 2012, and was succeeded by Serge Haroche.
Corvol is a researcher in the field of endocrine regulation of blood pressure and hypertension.
In particular, he was one of the discoverers of the hormone regulatory system, the renin angiotensin system, and the angiotensin converting enzyme.
His work contributes to the development of therapeutics blocking the renin-angiotensin-aldosterone system.
These drugs are widely used in the treatment of high blood pressure, heart failure and kidney failure in diabetics.
He was a pioneer of the genetics of high blood pressure in humans.
He has shown the importance of genetic markers in the renin system for predisposition to hypertension, cardiovascular disease and renal complications in diabetics.
On 9 December 2008, he became a full member of the (United States) National Academy of Medicine.
In 2016, he was commissioned by Thierry Mandon to report on scientific integrity, which encouraged a series of measures for scientific integrity in France, including the creation of the French Office for Scientific Integrity in 2017.
